Vascular effects of TZDs: new implications

Florian Blaschke¹, Robert Spanheimer, Mehmood Khan

¹Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

|June 3, 2006

Summary

Thiazolidinediones (TZDs) activate PPAR-gamma, improving type 2 diabetes and cardiovascular health. These drugs offer antiatherogenic effects by reducing inflammation and improving vessel wall markers.

Area of Science:

Endocrinology
Cardiovascular Medicine
Pharmacology

Background:

Type 2 diabetes affects over 170 million globally, increasing cardiovascular risks.
Thiazolidinediones (TZDs) are used to treat type 2 diabetes by enhancing insulin sensitivity.
TZDs activate peroxisome proliferator-activated receptor gamma (PPAR-gamma), impacting endothelial function and lipid profiles.

Purpose of the Study:

To review the role of PPAR-gamma agonists in the vessel wall.
To summarize the effects of TZDs on inflammatory markers and atherosclerosis.
To discuss implications for treating advanced atherosclerosis in type 2 diabetes patients.

Main Methods:

Literature review of studies on TZDs, PPAR-gamma, and atherosclerosis.
Analysis of TZD effects on specific biomarkers: C-reactive protein (CRP), plasminogen activator inhibitor type-1 (PAI-1), matrix metalloproteinase-9 (MMP-9), adiponectin, and ATP-binding cassette transporter A1 (ABCA1).

Main Results:

TZDs demonstrate antiatherogenic properties beyond their antidiabetic effects.
PPAR-gamma activation by TZDs modulates inflammatory processes within the vessel wall.
Evidence suggests TZDs positively influence key markers associated with atherosclerotic plaque stability and inflammation.

Conclusions:

PPAR-gamma agonists, like TZDs, play a significant role in managing atherosclerosis, especially in type 2 diabetes.
Modulation of inflammatory pathways and vessel wall markers by TZDs offers therapeutic potential.
Further research into TZDs' vascular effects could lead to improved treatment strategies for advanced cardiovascular disease.

Related Experiment Videos

Vascular effects of TZDs: new implications

Related Concept Videos

Prediction of appropriate implantable cardioverter-defibrillator therapy using machine learning and routinely available clinical data.

Experimental and Numerical Analysis of Titanium 3D Body-Centered Cubic Lattice Structure Additively Manufactured Using Selective Laser Melting.

Transthoracic signs of left atrial cardiomyopathy predict presence of left atrial thromboembolic substrate.

Left Ventricular Global Longitudinal Strain Predicts Pacemaker-Associated Cardiomyopathy with Substantial LVEF Deterioration: Results from a Single-Center Cohort Study in Germany.

Expanding the Role of Implantable Loop Recorders: Diagnostic and Therapeutic Yields Across Seven Clinical Indications in 388 Real-World Patients.

Angioplasty in Patients with Central Venous Occlusion Prior to Device Lead Implantation.

Aspirin and fibrin clot modulation in vascular pharmacology: Fibrinogen acetylation, disease context, and translational uncertainty.

Interplay between Na+/K+-ATPase-dependent Src-mediated Ca2+ sensitization and BKCa channel negative feedback regulates rat mesenteric artery contraction.

Generation and validation of a Myh11Dre-Spp1Cre intersectional mouse model for lineage tracing of disease-associated smooth muscle cell states.

Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement.

Vascularized tumor organoids as models for interpreting therapeutic response.

Spermidine ameliorates BK channel dysfunction in diabetic coronary smooth muscle cells via PKM2/STAT3/FBXO32 axis.

Related Experiment Videos

Vascular effects of TZDs: new implications

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles